Estiarte Martinez; Maria de los ngeles

Patent Applications and Registrations

Patent applications and USPTO patent grants for Estiarte Martinez; Maria de los ngeles.The latest application filed is for "arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use".

Company Profile

3.11.8

Estiarte Martinez; Maria de los ngeles - San Francisco CA
Estiarte-Martinez; Maria de los ngeles - Barcelona ES

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors Grant 10,329,256 - Ortega Munoz , et al.	2019-06-25
Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use Grant 10,233,178 - Ortega Munoz , et al.	2019-03-19
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors Grant 10,214,477 - Ortega Munoz , et al. Feb	2019-02-26
Arylcyclopropylamine Based Demethylase Inhibitors Of Lsd1 And Their Medical Use App 20180127406 - ORTEGA MUNOZ; Alberto ; et al.	2018-05-10
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors Grant 9,944,601 - Ortega Munoz , et al. April 17, 2	2018-04-17
(hetero)aryl Cyclopropylamine Compounds As Lsd1 Inhibitors App 20180079709 - ORTEGA MUNOZ; Alberto ; et al.	2018-03-22
Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use Grant 9,708,309 - Ortega Munoz , et al. July 18, 2	2017-07-18
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors Grant 9,670,136 - Ortega Munoz , et al. June 6, 2	2017-06-06
(hetero)aryl Cyclopropylamine Compounds As Lsd1 Inhibitors App 20170008844 - ORTEGA MUNOZ; Alberto ; et al.	2017-01-12
(hetero)aryl Cyclopropylamine Compounds As Lsd1 Inhibitors App 20160368857 - ORTEGA MUNOZ; Alberto ; et al.	2016-12-22
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors Grant 9,469,597 - Ortega Munoz , et al. October 18, 2	2016-10-18
Arylcyclopropylamine Based Demethylase Inhibitors Of Lsd1 And Their Medical Use App 20150376177 - ORTEGA MUNOZ; Alberto ; et al.	2015-12-31
Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use Grant 9,181,198 - Ortega Munoz , et al. November 10, 2	2015-11-10
Cyclopropylamine derivatives useful as LSD1 inhibitors Grant 9,006,449 - Fyfe , et al. April 14, 2	2015-04-14
(hetero)aryl Cyclopropylamine Compounds As Lsd1 Inhibitors App 20140256729 - Ortega Munoz; Alberto ; et al.	2014-09-11
Cyclopropylamine Derivatives Useful As Lsd1 Inhibitors App 20130197013 - Fyfe; Mathew Colin Thor ; et al.	2013-08-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.